rs8208
Positions:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_003134.6(SRP14):c.280C>T(p.Leu94=) variant causes a synonymous change. The variant allele was found at a frequency of 0.668 in 1,613,542 control chromosomes in the GnomAD database, including 370,519 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.58 ( 27466 hom., cov: 32)
Exomes 𝑓: 0.68 ( 343053 hom. )
Consequence
SRP14
NM_003134.6 synonymous
NM_003134.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.69
Genes affected
SRP14 (HGNC:11299): (signal recognition particle 14) Enables RNA binding activity. Involved in protein targeting to ER. Located in nucleus. Part of signal recognition particle, endoplasmic reticulum targeting. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 15-40036464-G-A is Benign according to our data. Variant chr15-40036464-G-A is described in ClinVar as [Benign]. Clinvar id is 402823.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.713 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRP14 | NM_003134.6 | c.280C>T | p.Leu94= | synonymous_variant | 5/5 | ENST00000267884.11 | NP_003125.3 | |
SRP14 | NM_001309434.1 | c.136C>T | p.Leu46= | synonymous_variant | 6/6 | NP_001296363.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRP14 | ENST00000267884.11 | c.280C>T | p.Leu94= | synonymous_variant | 5/5 | 1 | NM_003134.6 | ENSP00000267884 | P1 |
Frequencies
GnomAD3 genomes AF: 0.578 AC: 87754AN: 151794Hom.: 27465 Cov.: 32
GnomAD3 genomes
AF:
AC:
87754
AN:
151794
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.606 AC: 151508AN: 250066Hom.: 49097 AF XY: 0.620 AC XY: 84104AN XY: 135660
GnomAD3 exomes
AF:
AC:
151508
AN:
250066
Hom.:
AF XY:
AC XY:
84104
AN XY:
135660
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.677 AC: 989993AN: 1461630Hom.: 343053 Cov.: 74 AF XY: 0.678 AC XY: 492973AN XY: 727120
GnomAD4 exome
AF:
AC:
989993
AN:
1461630
Hom.:
Cov.:
74
AF XY:
AC XY:
492973
AN XY:
727120
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.578 AC: 87765AN: 151912Hom.: 27466 Cov.: 32 AF XY: 0.574 AC XY: 42612AN XY: 74254
GnomAD4 genome
AF:
AC:
87765
AN:
151912
Hom.:
Cov.:
32
AF XY:
AC XY:
42612
AN XY:
74254
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1440
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at